Allyx Therapeutics: Funding, Investors & Team (Oct 2026)
Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies designed to reverse neurodegeneration. Allyx Therapeutics' product is an orally bioavailable small molecule that acts as a silent allosteric modulator, enabling clinicians to get a drug that is capable of delivering a disease-modifying approach and preserve cognition in patients.
Allyx Therapeutics has raised $7.6M across 1 funding round on record, the most recent an undisclosed round of $7.6M announced in Jun 2021.
That round is in line with the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Allyx Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2021.
Allyx Therapeutics Funding Rounds
Allyx Therapeutics Founders and Leadership Team
Contact details for the Allyx Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Allyx Therapeutics Funding Compared to Other Biotechnology Startups
Allyx Therapeutics' latest round of $7.6M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Allyx Therapeutics in Biotechnology and New Haven
Companies Similar to Allyx Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Allyx Therapeutics Funding FAQs
What does Allyx Therapeutics do?
Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies designed to reverse neurodegeneration. Allyx Therapeutics' product is an orally bioavailable small molecule that acts as a silent allosteric modulator, enabling clinicians to get a drug that is capable of delivering a disease-modifying approach and preserve cognition in patients.
How much funding has Allyx Therapeutics raised?
Allyx Therapeutics has raised $7.6M across 1 round on record. The most recent is an undisclosed round of $7.6M announced in Jun 2021.
When did Allyx Therapeutics last raise funding?
Allyx Therapeutics' most recent funding round on record is an undisclosed round of $7.6M, announced in Jun 2021.
Who is the CEO of Allyx Therapeutics?
Stephen Bloch is listed as CEO at Allyx Therapeutics.
Where is Allyx Therapeutics headquartered?
Allyx Therapeutics is based in New Haven, New York, United States.
How many employees does Allyx Therapeutics have?
Allyx Therapeutics is in the 1-10 employee band.
How does Allyx Therapeutics' funding compare to other Biotechnology startups?
Allyx Therapeutics' latest round of $7.6M is in line with the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Allyx Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Allyx Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.